While prostate cancer is becoming more prevalent among middle-aged and elderly men in China, clinical practice still faces considerable challenges due to the lack of unified guidelines and high-level evidence on several aspects of patient care. Despite the publication of various international and domestic guidelines, many crucial areas remain unclear, particularly in the management of localized and metastatic prostate cancer. This consensus is a timely response to these challenges, providing a unified framework that can serve as a reference for clinicians throughout the patient journey.
On October 10, 2024, a consensus was published (DOI: 10.1002/uro2.76) in the journal UroPrecision. The document is the result of in-depth discussions and voting by a panel of leading experts, including urologists, medical…